![EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease](https://i.ytimg.com/vi/6wEm3rHv9YM/maxresdefault.jpg)
EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease
![EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease](https://covalentcareers3.s3.amazonaws.com/media/original_images/Eysuvis-3.png)
EYSUVIS™: The First Prescription Therapy Specifically Developed for the Short-Term Treatment of Dry Eye Disease
![Kala Pharmaceuticals' Eysuvis Can Be A Rock Star In The Dry Eye Market (NASDAQ:KALA) | Seeking Alpha Kala Pharmaceuticals' Eysuvis Can Be A Rock Star In The Dry Eye Market (NASDAQ:KALA) | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/2/7/52848637-16127117818175614_origin.jpg)
Kala Pharmaceuticals' Eysuvis Can Be A Rock Star In The Dry Eye Market (NASDAQ:KALA) | Seeking Alpha
![Kala Pharmaceuticals' Eysuvis Can Be A Rock Star In The Dry Eye Market (NASDAQ:KALA) | Seeking Alpha Kala Pharmaceuticals' Eysuvis Can Be A Rock Star In The Dry Eye Market (NASDAQ:KALA) | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/2/7/52848637-16127132838364937_origin.png)